Armata Pharmaceuticals, Inc.（ARMP）價格預測ARMPArmata Pharmaceuticals, Inc.

Alphio's ARMP stock price prediction model matches the current Armata Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.04 (+1.20%). The 1-week path is $3.10 (+3.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Armata Pharmaceuticals Inc (ARMP) is not a good buy. The stock is trading at $2.85, which is significantly down from its 52-week high of $14.98, representing a decline of approximately 81%. Additionally, the Relative Strength Index (RSI) is at 28.706, indicating that the stock is oversold, but this could also suggest continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the company has a gross margin of 100%, but this is overshadowed by substantial losses, including a net income loss of $115.3 million in Q1 2026. The main risk is the high volatility, with a historical volatility of 109.46%.

Armata Pharmaceuticals, Inc. (ARMP) last closed at $3, losing -4.46%. These facts feed the 1-day and 1-week ARMP price prediction above.